Xtant Medical Holdings Inc Capital Reinvestment Ratio

Latest as of December 2025: 0.07x

Xtant Medical Holdings Inc capital reinvestment ratio. Xtant Medical Holdings Inc (XTNT) has a Capital Reinvestment Ratio of 0.07x as of December 2025, meaning it reinvests 0% of its operating cash flow ($5.38 Million) in capital expenditures ($395.00K). See free cash flow generation of Xtant Medical Holdings Inc to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.07x
Capex / Operating Cash Flow

Operating Cash Flow

$5.38 Million
USD

Capital Expenditures

$395.00K
USD

Data as of

Dec 2025
Most recent filing

Capital Reinvestment Ratio of Xtant Medical Holdings Inc (2018–2025)

Capital reinvestment ratio of Xtant Medical Holdings Inc from 2018 to 2025. This chart tracks Xtant Medical Holdings Inc's Capital Reinvestment Ratio across 3 annual periods. See financial agility of Xtant Medical Holdings Inc to measure the company's free cash flow as a share of total liabilities.

Xtant Medical Holdings Inc Capital Reinvestment Ratio by Year (2018–2025)

Xtant Medical Holdings Inc capital reinvestment ratio by year from 2018 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of Xtant Medical Holdings Inc.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.19x $12.55 Million $2.38 Million ▼ -96.1%
2021 4.82x $439.00K $2.12 Million ▲ +835.8%
2018 0.51x $1.21 Million $624.00K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow